A phase I study of sequential vaccinations with recombinant Fowlpox-PSA (L155)-TRICOM (rF)alone, or in combination with recombinant vaccinia-PSA (L155)-TRICOM (rV), and the role of GM-CSF, in patients (Pts) with prostate cancer
Philip M. Arlen(Dana-Farber Cancer Institute), Jeffrey Schlom(National Cancer Institute), Dennis Panicali(Fox Chase Cancer Center), William Dahut, James L. Gulley(National Cancer Institute), Mary Pazdur(National Institutes of Health), Steven Morin(National Institutes of Health), Lisa Skarupa(National Institutes of Health), N R Todd, K. Y. Tsang
Cited by 10
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975